Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 167,988 shares at $28.23 ($4.7M) on 2025-04-16, disclosed to the SEC on 2025-04-18.
Scheduled sale ($4.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.02 | 33,668 | $943K | 20.0% |
| 2 | $28.02 | 33,668 | $943K | 20.0% |
| 3 | $28.23 | 47,534 | $1.3M | 28.4% |
| 4 | $28.23 | 47,534 | $1.3M | 28.4% |
| 5 | $28.31 | 2,792 | $79K | 1.7% |
| 6 | $28.31 | 2,792 |
| $79K |
| 1.7% |
| Total | $28.15 avg | 167,988 | $4.7M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |